Myriad Genetics
MYGN
#7306
Rank
A$0.79 B
Marketcap
A$8.44
Share price
-0.17%
Change (1 day)
24.35%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -A$0.59 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are A$0.82 Billion. In 2025 the company made an earning of -A$0.55 Billion a decrease over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.59 Billion6.35%
2025 -A$0.55 Billion218.91%
2024 -A$0.18 Billion-53.49%
2023 -A$0.38 Billion88.72%
2022 -A$0.2 Billion172.08%
2021 -A$72.14 Million
2019 -A$37.57 Million-175.14%
2018 A$49.99 M-70.81%
2017 A$0.17 B22.22%
2016 A$0.14 B-38.8%
2015 A$0.22 B-6.12%
2014 A$0.24 B-41.07%
2013 A$0.41 B46.67%
2012 A$0.28 B15.84%
2011 A$0.24 B17.6%
2010 A$0.20 B-15.96%
2009 A$0.24 B
2007 -A$59.54 Million40.96%
2006 -A$42.24 Million
2003 -A$49.05 Million34.8%
2002 -A$36.39 Million89.21%
2001 -A$19.23 Million3.93%
2000 -A$18.51 Million21.76%
1999 -A$15.2 Million-25.61%
1998 -A$20.43 Million38.83%
1997 -A$14.72 Million-24.26%
1996 -A$19.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
A$11.62 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-A$0.27 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55 B-199.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$49.95 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$0.31 B-157.59%๐Ÿ‡บ๐Ÿ‡ธ USA